The differentiation between exudates and transudates is the initial step in the analysis of pleural effusions as it often gives an indication of the underlying pathophysiologic process, the differential diagnosis, and the need for further investigations The following biochemical parameters were determined on all pleural fluids: total protein, albumin, total cholesterol, lactate dehydrogenase (LDH), and total bilirubin. A sample of serum (preferably simultaneous, but accepted within 24 h of thoracentesis) was obtained to determine the above parameters.
Pleural effusions often pose a diagnostic dilemma to the physician' as the differential diagnosis is wide and may indicate the presence of pleural, pulmonary, or extrapulmonary disease. The initial step is the distinction between transudates and exudates, as this gives an indication of the pathophysiologic mechanisms, the differential diagnoses, and the need for further investigations.
Because of their high sensitivity in identifying exudates, the criteria proposed by Light et vestigations, such as pleural biopsy, were done at the discretion of the primary physician.
Biochemical parameters were determined using a multichannel analyzer (Technicon DAX 48). Total protein concentration (grams per liter) was estimated using the biuret method and albumin concentration (grams per liter) was measured using bomocresol green, both of which are spectrophotometric methods. Total cholesterol concentration (millimol per liter) was determined by an enzymatic spectrophotometric method (cholesterol esterase and cholesterol oxidase). The concentration of total bilirubin (micromol per liter) was determined by measurement of azobilirubin after reaction with diazotized sulfanilic acid and addition of an accelerator. The LDH value (units per liter) was measured using an enzymatic UV optimized method.
The hospital records of all patients were reviewed, independent of the pleural fluid biochemical data, and a diagnosis was recorded. Effusions were classified into the following diagnostic groups defined by the following predetermined criteria:
( Four of the 256 patients having exudates were misclassified as having transudates. Two of these patients had malignancies: 1 was secondary to a pulmonary embolus and the remaining patient had tuberculous pleuritis (diagnosed by the presence of a positive sputum culture in the presence of clinical and radiologic evidence for TB).
Of those with transudates, 19 of 112 were misclassified. These consisted of 2 patients with liver cirrhosis (whose albumin gradients were 15 and 13, respectively); 11 patients with CHF (8 of whom had albumin gradients that fell in the transudative range, being 13, 17, 18, 19, 20, 20, 21 Of the exudates, 192 of 221 were correctly classified, yielding a sensitivity for exudates of 87%. The 29 exudates that were incorrectly classified consisted of 14 malignancies, 7 TB, 7 infective diseases, and 1 chylothorax. Applying the criteria of Light et al,2 26 of these were classified as exudates. In the case of the patient with a chylothorax, the patient had TB lymphadenitis (proved on lymph node biopsy specimen and culture). The triglyceride level was 9 mmol/L, and lipoprotein electrophoresis showed an obvious cathodal chylomicron peak. Applying the criteria of Light et al, the P/S protein ratio, P/S LDH ratio, and pleural fluid LDH concentration in this specimen were 0.192, 0.7816, and 136, respectively, suggesting the possibility of a dual pathophysiologic mechanism for the effusion.
The specificity of the serum-effusion albumin gradient could be calculated as 92%, based on the fact that 98 of 106 transudates were correctly classified. These consisted of 4 patients with CHF (2 of whom were also classified as having exudates by application of the criteria of Light et a12); 2 renal failure (1 of whom was also classified as having an exudate by the criteria of Light et a12; and 2 hypoalbuminemia (1 of whom was also classified as having an exudate by the criteria of Light et a12).
The ppv and npv for the identification of exudates were 96% and 77%, respectively.
Various other cutoff levels for the serum-effusion albumin gradient were tested, but this did not increase the sensitivity or specificity of the test.
Pleural Effusion Cholesterol Concentration
Based on previous studies6'7 done in this area, a cutoff point of 60 mg/dl (1.55 mmol/L) yielded the best results. Exudates were classified as having a cholesterol concentration greater than 60 mg/dL, and transudates less than 60 mg/dL. Using this cutoff level, 235 of 352 effusions were correctly classified. This yielded an accuracy, sensitivity, and specificity (for exudates) of 70%, 54%, and 92%, respectively.
Of the 236 exudates, only 128 were correctly classified, while 107 of the 116 transudates were correctly classified. The 9 transudates that were misclassified consisted of renal failure, 3 (of which only 1 was correctly classified by the criteria of Light et a12); CHF, 5 (of which all were misclassified by the criteria of Light et a12); and hypoalbuminemia, 1 (which was correctly classified by the criteria of Light et a12). The ppv and npv were 93% and 50%, respectively. Different cutoff levels for cholesterol were applied, as shown in Table 2 . This demonstrated that better results could be obtained at lower pleural fluid cholesterol levels. Use of pleural effusion/serum cholesterol gradients did not affect our results. Pleural fluid/serum (P/S) cholesterol ratios were also calculated at various cutoff points, as shown in Table 3 . Although Hamm et a16 showed that application of a P/S cholesterol ratio did not affect the sensitivity and specificity of this test, this was not the case in our population. Using a cutoff value of 0.25 yielded an accuracy, sensitivity, and specificity of 86%, 92%, and 71%, respectively; increasing the cutoff point to 0.3 yielded results of 87%, 89%, and 81%, respectively.
Pleural/Serum Bilirubin Ratio
Meisel et a19 described exudates as having pleural/ serum (P/S) bilirubin ratio 20.6. The P/S bilirubin ratios were calculated in 318 patients in the present study. As found previously, best results were obtained using a cutoff level of 0.6. Of the 216 exudates, 175
were correctly classified, and 62 of 102 transudates were correctly classified. Accuracy, sensitivity, and specificity for the detection of exudates were 75%, 81%, and 61%, respectively. The ppv was 81% and the npv was 61%.
DISCUSSION
Separation of exudates from transudates remains a useful initial step in determining the cause of a pleural effusion and the decision as to whether further, and often more invasive, investigations should be carried out on the patient.'4 Historically, specific gravity was used to separate these two entities15; later, Hamm et a16 suggested the use of cholesterol levels in distinguishing between transudates and exudates. Their findings, later confirmed by Valdes et al,7 were found to be 100% sensitive and 95% specific. Romero et al,10 however, did not agree with these results. From the present study, effusion cholesterol concentration was found to be a poor method for distinguishing between transudates and exudates. Application of a cutoff point of 1.55 mmol/L yielded a sensitivity and specificity of 54% and 92%, respectively. Using lower cutoff levels yielded better results: a cutoff point of 1.40 yielded a sensitivity and specificity of 63% and 91%, respectively; a cutoff point of 1.30 yielded a sensitivity and specificity of 68% and 91%, respectively; and a cutoff point of 1.20 yielded a sensitivity and specificity of 72% and 85%, respectively. However, the results were still not as reliable as those found by the preceding methods.
According to Hamm et al,6 calculation of the pleural fluid/serum cholesterol ratio and application of a dividing line of -0.3 to characterize exudates did not substantially change the results determined by the pleural fluid cholesterol level. From this, they concluded that the cholesterol level in pleural effusion is the result of the underlying disease rather than a reflection of the serum cholesterol level. In the present study, however, the cholesterol level in the pleural fluid appears to be dependent on the serum cholesterol level. When the pleural fluid/serum cholesterol ratio was calculated, the sensitivity and specificity improved to 89% and 81%, respectively, when a dividing line .0.3 was used to characterize exudates; and a sensitivity and specificity of 92% and 71%, respectively, when a dividing line -0.2 was used.
The distinction between transudates and exudates according to the pleural fluid/serum bilirubin concentration ratio was investigated by Meisel et a19 and yielded a sensitivity and specificity of 96% and 83%, respective, compared with 90% and 82% yielded with the application of the criteria of Light et al.2 In the present study, a sensitivity and specificity of 81% and 61%, respectively, were obtained.
Laboratory tests are a useful guideline when assessing the etiology and pathophysiology of pleural effusions. The results of the various tests are summarized in Table 4 . We have demonstrated that the use of the criteria of Light et a12 is still the method of choice for distinguishing between transudates and exudates. Application of the serum-effusion albumin gradient is important in those cases where the patient is receiving concurrent diuretic therapy. The P/S cholesterol ratios may provide a clue as to the nature of the pleural effusion in dubious cases. The use of effusion cholesterol levels and P/S bilirubin ratios does not appear to apply to our population.
Many of the parameters used for identifying exudates are based on the fact that pleural exudates more closely resemble plasma than transudates. Pleural/ serum ratios of various other parameters (including aspartate transaminase, alanine transaminase, alkaline pho.sphatase, and y-glutamyltransferase) were therefore also considered. However, no significant or accurate differences were found.
Recent experimental and clinical studies suggest that the classical theory on the origin of pleural effusions needs to be modified. Transudates have been shown to arise from the interstitial space of the lung in sheep.25 Moreover, the pleural fluid contains the same protein concentration as do the lung lymph and the interstitial edema liquid in the lung.26 This, coupled with the fact that patients with CHF demonstrate a close correlation between the presence of pleural effusions and pulmonary venous pressure,27 suggests that the interstitial space of the lungs acts as an origin of the effusion and a route by which edema liquid clears the lung.19 There is evidence to suggest that high-protein exudates, found in association with increased permeability pulmonary edema, probably also arise from the lung interstitium. 19'28 This may lead one to question the practice of differentiating between pleural exudates and transudates. However, whether the fluid arises from the pleura, the peritoneum, or the lungs, this classification still indicates whether the fluid results from imbalances in hydrostatic and osmotic forces or from increased permeability.19 It is important, however, that when making this distinction, laboratory tests are interpreted in conjunction with the physician's clinical acumen.
